Testosterone Concentrations in Hair of Hypogonadal Men With and Without Testosterone Replacement Therapy

被引:15
|
作者
Thomson, Steven [1 ]
Koren, Gideon [1 ,2 ,3 ,4 ]
Van Steen, Veronique [3 ]
Rieder, Michael [1 ,2 ,3 ,5 ]
Van Uum, Stan H. M. [3 ]
机构
[1] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada
[2] Univ Western Ontario, Dept Pediat, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada
[3] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada
[4] Univ Western Ontario, Ivey Chair Mol Toxicol, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada
[5] Univ Western Ontario, GSK Chair Pediat Clin Pharmacol, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada
关键词
hair; testosterone; hypogonadism; androgen; replacement; ANDROGEN DEFICIENCY; CORTISOL; IDENTIFICATION; BIOMARKER; STRESS; ESTERS;
D O I
10.1097/FTD.0b013e3181c004f1
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The measurement of testosterone (T) is essential for the diagnosis of male hypogonadism and for monitoring treatment. Samples need to be obtained at specific times in relation to the diurnal rhythm and therapeutic T injections. In this study, we explored the measurement of T in hair as an alternative method to assess gonadal status and long-term T exposure in men. Subjects and Methods: Thirty-six male subjects comprising 17 healthy volunteers, 10 untreated hypogonadal men, and nine hypogonadal men receiving T injections were studied. T was measured in serum and in hair. T in hair was measured using a commercially available salivary T enzyme immunoassay kit adapted for this use. Results: The T concentration in the hair of hypogonadal men receiving T injections was significantly higher than that in untreated hypogonadal volunteers, but not eugonadal men. Median T concentrations were 3.66 (range, 0.82-15.00), 0.94 (range, 0.33-3.68), and 1.85 (range, 0.58-3.06) pg/g hair, respectively. Conclusions: T in hair reflects gonadal status in men and may be useful for monitoring T therapy over several weeks to months in hypogonadal men.
引用
收藏
页码:779 / 782
页数:4
相关论文
共 50 条
  • [31] Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy
    Bernini, G
    Versari, D
    Moretti, A
    Cipriano, A
    Virdis, A
    Ghiadoni, L
    Bardini, M
    Taurino, C
    Taddei, S
    Salvetti, A
    JOURNAL OF HYPERTENSION, 2005, 23 : S211 - S211
  • [32] Testosterone Replacement Therapy Improves QTaVI in Hypogonadal Men with Spinal Cord Injury
    La Fountaine, Michael F.
    Wecht, Jill M.
    Cirnigliaro, Christopher M.
    Kirshblum, Steven C.
    Spungen, Ann M.
    Bauman, William A.
    NEUROENDOCRINOLOGY, 2013, 97 (04) : 341 - 346
  • [33] Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy
    Bernini, G
    Versari, D
    Moretti, A
    Cipriano, A
    Virdis, A
    Ghiadoni, L
    Bardini, M
    Taurino, C
    Taddei, S
    Salvetti, A
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 177A - 177A
  • [34] TESTOSTERONE REPLACEMENT THERAPY IN OPIOID-INDUCED HYPOGONADAL MEN: A PROSPECTIVE ANALYSIS
    Sisul, D.
    Acevedo, J.
    Raheem, O.
    Hsieh, T.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 119 - 120
  • [35] TESTOSTERONE REPLACEMENT THERAPY IN HYPOGONADAL MEN UNDERGOING ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Berookhim, B.
    Krishnan, R.
    Nelson, C. J.
    Mulhall, J. P.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 147 - 148
  • [36] Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy
    Bernini, G
    Versari, D
    Moretti, A
    Virdis, A
    Ghiadoni, L
    Bardini, M
    Taurino, C
    Canale, D
    Taddei, S
    Salvetti, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (05): : 1691 - 1697
  • [37] Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men
    Angelova, Petya
    Momchilova, Albena
    Petkova, Diana
    Staneva, Galya
    Pankov, Roumen
    Kamenov, Zdravko
    AGING MALE, 2012, 15 (03): : 173 - 179
  • [38] Testosterone replacement therapy in hypogonadal men: Assessing benefits, risks, and best practices
    Miner, Martin
    Canty, David J.
    Shabsigh, Ridwan
    POSTGRADUATE MEDICINE, 2008, 120 (03) : 130 - 153
  • [39] Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism
    Pencina, Karol M.
    Travison, Thomas G.
    Cunningham, Glenn R.
    Lincoff, A. Michael
    Nissen, Steven E.
    Khera, Mohit
    Miller, Michael G.
    Flevaris, Panagiotis
    Li, Xue
    Wannemuehler, Kathleen
    Bhasin, Shalender
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (02): : 569 - 580
  • [40] Testosterone Replacement Therapy and Cardiovascular Disease: Balancing Safety and Risks in Hypogonadal Men
    Blackwell, Kelli
    Blackwell, Michele
    Blackwell, Thomas
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (10) : 1157 - 1163